SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Monday reported a loss of $39.3 million in its fiscal second quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 66 cents.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 56 cents per share.
The maker of synthetic DNA for the biotechnology industry posted revenue of $92.8 million in the period, which topped Street forecasts. Four analysts surveyed by Zacks expected $91.9 million.
For the current quarter ending in June, Twist Bioscience said it expects revenue in the range of $94 million to $97 million.
The company expects full-year revenue in the range of $372 million to $379 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TWST at https://www.zacks.com/ap/TWST
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
